MOESM1 of Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli
2017-03-27T05:00:00Z (GMT) by
Additional file 1: Table S1. The summary of strains and plasmids used in the present study. Table S2. The summary of the primers used in the present study.